Physician profile
Sawyer Lambert
NPI 1437716289
$6,983.29
in general payments reported to CMS, 2019-2025
15 companies · $900 in 2025
The $900 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $74.16 · 2021: $758 · 2022: $891 · 2023: $3,065 · 2024: $1,196 · 2025: $900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,790 · Travel and Lodging: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,789.68 |
| Travel and Lodging | $1,370.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,169.97 | 2021-2025 | Total30, Dailies Total1, Precision 1 |
| Biotissue Holdings INC. | $1,708.34 | 2022-2023 | |
| Oyster Point Pharma, INC. | $791.51 | 2022-2024 | Tyrvaya |
| Bausch & Lomb Americas INC. | $625.91 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Coopervision INC. | $596.49 | 2020-2023 | Myday Contact Lens, Misight Contact Lens, Biofinity Contact Lens |
| Dompe US, INC. | $392.09 | 2023-2025 | Oxervate |
| Harrow Eye, LLC | $148.46 | 2025 | Vevye |
| Lkc Technologies, INC. | $137.05 | 2024 | |
| Rxsight INC | $103.41 | 2022 | |
| Genzyme Corporation | $100.00 | 2019 | |
| Amgen INC. | $86.32 | 2024 | Tepezza |
| Novartis Pharmaceuticals Corporation | $69.43 | 2023 | |
| Sight Sciences, INC. | $20.52 | 2023 | Tearcare System |
| Tarsus Pharmaceuticals, INC. | $17.05 | 2024 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $16.74 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sawyer Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.